Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Neurosurgery
|
April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
William A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Current Problems in Cancer
|
June 15, 2010
ACR Appropriateness Criteria: single brain metastasis
John H Suh, Gregory M M Videtic, Amr M Aref, et al.
Journal of Neuro-Oncology
|
October 29, 2015
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
H Ian Robins, Peixin Zhang, Mark R Gilbert, et al.
Neuro-Oncology
|
August 15, 2014
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Elizabeth Vera-Bolanos, Kenneth Aldape, Ying Yuan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 28, 2009
American College of Radiology appropriateness criteria on multiple brain metastases
, Gregory M M Videtic, Laurie E Gaspar, et al.
Neuro-Oncology Practice
|
December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525
H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Neuro-Oncology
|
August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Neurosurgery
|
April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
William A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Current Problems in Cancer
|
June 15, 2010
ACR Appropriateness Criteria: single brain metastasis
John H Suh, Gregory M M Videtic, Amr M Aref, et al.
Journal of Neuro-Oncology
|
October 29, 2015
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
H Ian Robins, Peixin Zhang, Mark R Gilbert, et al.
Neuro-Oncology
|
August 15, 2014
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Elizabeth Vera-Bolanos, Kenneth Aldape, Ying Yuan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 28, 2009
American College of Radiology appropriateness criteria on multiple brain metastases
, Gregory M M Videtic, Laurie E Gaspar, et al.
Neuro-Oncology Practice
|
December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525
H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma
Jessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Neuro-Oncology
|
August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Page
of 12